Literature DB >> 10377393

Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication.

O Flores1, G Lee, J Kessler, M Miller, W Schlief, J Tomassini, D Hazuda.   

Abstract

HIV-1 gene expression and viral replication require the viral transactivator protein Tat. The RNA polymerase II transcriptional elongation factor P-TEFb (cyclin-dependent kinase 9/cyclin T) is a cellular protein kinase that has recently been shown to be a key component of the Tat-transactivation process. For this report, we studied the requirement for P-TEFb in HIV-1 infection, and we now show that P-TEFb is both essential and limiting for HIV-1 replication. Attenuation of P-TEFb kinase activity either by expression of a dominant-negative cyclin-dependent kinase 9 transgene or through the use of small-molecule inhibitors suppresses HIV-1 gene expression and HIV-1 replication. Inhibition of HIV-1 replication is affected in a manner consistent with a direct and specific effect on P-TEFb and the known functional role of P-TEFb in Tat-activated transcription. Tat-activated expression of HIV-1 genes seems uniquely dependent on P-TEFb, as inhibition of P-TEFb activity and HIV-1 replication can be achieved without compromising cell viability or RNA polymerase II-dependent cellular gene transcription. Selective inhibition of the P-TEFb kinase may therefore provide a novel approach for developing chemotherapeutic agents against HIV-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377393      PMCID: PMC22054          DOI: 10.1073/pnas.96.13.7208

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 2.  The unique C-terminal domain of RNA polymerase II and its role in transcription.

Authors:  M E Kang; M E Dahmus
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1995

Review 3.  Reversible phosphorylation of the C-terminal domain of RNA polymerase II.

Authors:  M E Dahmus
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

4.  Transcriptional regulation of hemoglobin switching in chicken embryos.

Authors:  M Groudine; M Peretz; H Weintraub
Journal:  Mol Cell Biol       Date:  1981-03       Impact factor: 4.272

Review 5.  The role of multisite phosphorylation in the regulation of RNA polymerase II activity.

Authors:  M E Dahmus
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1994

6.  Purification of P-TEFb, a transcription factor required for the transition into productive elongation.

Authors:  N F Marshall; D H Price
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

7.  PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro.

Authors:  X Graña; A De Luca; N Sang; Y Fu; P P Claudio; J Rosenblatt; D O Morgan; A Giordano
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

9.  Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors.

Authors:  V W Byrnes; V V Sardana; W A Schleif; J H Condra; J A Waterbury; J A Wolfgang; W J Long; C L Schneider; A J Schlabach; B S Wolanski
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.

Authors:  P D Bieniasz; T A Grdina; H P Bogerd; B R Cullen
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

View more
  33 in total

Review 1.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 2.  Chemical approaches to control gene expression.

Authors:  J M Gottesfeld; J M Turner; P B Dervan
Journal:  Gene Expr       Date:  2000

3.  Regulation of P-TEFb elongation complex activity by CDK9 acetylation.

Authors:  Junjiang Fu; Ho-Geun Yoon; Jun Qin; Jiemin Wong
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

4.  Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells.

Authors:  S M Foskett; R Ghose; D N Tang; D E Lewis; A P Rice
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines.

Authors:  R Ghose; L Y Liou; C H Herrmann; A P Rice
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2.

Authors:  Masanori Nojima; Yehong Huang; Mudit Tyagi; Hung-Ying Kao; Koh Fujinaga
Journal:  J Mol Biol       Date:  2008-07-16       Impact factor: 5.469

7.  Identification of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replication.

Authors:  Akbar Ali; Animesh Ghosh; Robin S Nathans; Natalia Sharova; Siobhan O'Brien; Hong Cao; Mario Stevenson; Tariq M Rana
Journal:  Chembiochem       Date:  2009-08-17       Impact factor: 3.164

8.  Selective control of gene expression by CDK9 in human cells.

Authors:  Judit Garriga; Hongbo Xie; Zoran Obradovic; Xavier Graña
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

9.  Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat.

Authors:  Lisa Muniz; Sylvain Egloff; Bettina Ughy; Beáta E Jády; Tamás Kiss
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

10.  Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription.

Authors:  Qi Wang; Tara M Young; Michael B Mathews; Tsafi Pe'ery
Journal:  J Mol Biol       Date:  2007-01-12       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.